ARCHIVES

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

This article is from The Cancer Letter archive.

Vol. 11 No. 42 | November 1, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Supreme Court Upholds Affordable Care Act in 5-4 Decision, Narrows Medicaid Provision

June 29, 2012

HEW Money Bills Mark Up Set May 26

May 20, 1977

Institutions Fail To Credit NIH when Patenting discoveries, HHS Says

July 15, 1994

FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate.

May 28, 2004

DuBois Succeeds Hait As AACR President, Jacks Is President-Elect.

April 18, 2008